At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 270 enrolled
Drug / intervention
therapeutic conventional surgery +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmesis in Patients With Multiple Ipsilateral Breast Cancers (MIBC)
In Brief
A Phase 2 clinical trial evaluating therapeutic conventional surgery and whole breast irradiation for Breast Cancer. Completed, enrolled 270 participants across 350 sites.
Detailed Summary
RATIONALE: Breast-conserving surgery is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery. Radiation therapy uses high-energy x rays to kill tumor cells. Giving radiation therapy after surgery may kill any tumor cells that remain after surgery. PURPOSE: This phase II trial studies how well breast-conserving surgery and radiation therapy work in treating patients with multiple ipsilateral breast cancer
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 2012
Enrollment StartJul 2012
Primary CompletionJun 2022
Study CompletionApr 2023
TodayJul 2026
First PostedMar 16, 2012
Enrollment StartJul 1, 2012
Primary CompletionJun 1, 2022
Study CompletionApr 15, 2023
TodayJul 2, 2026
Enrollment to primary: 9.9 yearsPosted 14.3 years ago
Interventions
therapeutic conventional surgeryprocedure
whole breast irradiationradiation